Involvement of Spinal Bv8/Prokineticin 2 in a Rat Model of Cancer-Induced Bone Pain

Basic and Clinical Pharmacology and Toxicology

Volumn 117, Issue 3, 2015, Pages 180-185

  Hang, Li Hua ^a   Luo, Hong ^a   Li, Shu Na ^a   Shu, Wei Wei ^a   Chen, Zheng ^a   Chen, Yuan Feng ^a   Yuan, Ju Fang ^a   Shi, Lei Lei ^a   Shao, Dong Hua ^a  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BV8 NEUTRALIZING ANTIBODY; BV8 PROTEIN; CHEMOKINE; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GASTROINTESTINAL HORMONE; NEUROPEPTIDE; PROK2 PROTEIN, RAT;

ANIMAL MODEL; ARTICLE; ATTENUATION; BONE PAIN; CANCER INDUCED BONE PAIN; CANCER PAIN; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MECHANICAL HYPERALGESIA; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SPINAL CORD DORSAL HORN; SPINE; TIBIA; TUMOR CELL; WALKER CARCINOMA; ANIMAL; BONE TUMOR; CANCER TRANSPLANTATION; CARCINOMA; CHEMISTRY; COMPLICATION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; METASTASIS; PAIN; PAIN MEASUREMENT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

RATTUS;

ANIMALS; BLOTTING, WESTERN; BONE NEOPLASMS; CARCINOMA 256, WALKER; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL HORMONES; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEUROPEPTIDES; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938503033     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12386     Document Type: Article

References (31)

1. Mantyh P. Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain 2013;154:S54-62.
2. Mantyh PW. Bone cancer pain: from mechanism to therapy. Curr Opin Support Palliat Care 2014;8:83-90.
3. Wilson J, Stack C, Hester J. Recent advances in cancer pain management. F1000Prime Rep 2014;6:10.
4. Lozano-Ondoua AN, Symons-Liguori AM, Vanderah TW. Cancer-induced bone pain: mechanisms and models. Neurosci Lett 2013;557:52-9.
5. Mollay C, Wechselberger C, Mignogna G, Negri L, Melchiorri P, Barra D et al. Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur J Pharmacol 1999;374:189-96.
6. Negri L, Lattanzi R. Bv8-prokineticins and their receptors: modulators of pain. Curr Pharm Biotechnol 2011;12:1720-7.
7. Giannini E, Lattanzi R, Nicotra A, Campese AF, Grazioli P, Screpanti I et al. The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc Natl Acad Sci U S A 2009;106:14646-51.
8. Qiu CY, Liu YQ, Qiu F, Wu J, Zhou QY, Hu WP. Prokineticin 2 potentiates acid-sensing ion channel activity in rat dorsal root ganglion neurons. J Neuroinflammation 2012;9:108.
9. Negri L, Lattanzi R. Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system. Curr Opin Pharmacol 2012;12:62-6.
10. Negri L, Lattanzi R, Giannini E, Metere A, Colucci M, Barra D et al. Nociceptive sensitization by the secretory protein Bv8. Br J Pharmacol 2002;137:1147-54.
11. Maftei D, Marconi V, Florenzano F, Giancotti LA, Castelli M, Moretti S et al. Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals. Br J Pharmacol 2014;171:4850-65.
12. Falk S, Dickenson AH. Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol 2014;32:1647-54.
13. Quintans JS, Antoniolli AR, Almeida JR, Santana-Filho VJ, Quintans-Júnior LJ. Natural products evaluated in neuropathic pain models - a systematic review. Basic Clin Pharmacol Toxicol 2014;114:442-50.
14. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-10.
15. Hang LH, Yang JP, Yin W, Wang LN, Guo F, Ji FH et al. Activation of spinal TDAG8 and its downstream PKA signaling pathway contribute to bone cancer pain in rats. Eur J Neurosci 2012;36:2107-17.
16. Hang LH, Shao DH, Chen Z, Chen YF, Shu WW, Zhao ZG. Involvement of spinal CC chemokine ligand 5 in the development of bone cancer pain in rats. Basic Clin Pharmacol Toxicol 2013;113:325-8.
17. Hang LH, Shao DH, Chen Z, Sun WJ. Spinal RhoA/Rho kinase signalling pathway may participate in the development of bone cancer pain. Basic Clin Pharmacol Toxicol 2013;113:87-91.
18. Hang LH, Yang JP, Shao DH, Chen Z, Wang H. Involvement of spinal PKA/CREB signaling pathway in the development of bone cancer pain. Pharmacol Rep 2013;65:710-6.
19. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53:55-63.
20. Gui Q, Xu C, Zhuang L, Xia S, Chen Y, Peng P et al. A new rat model of bone cancer pain produced by rat breast cancer cells implantation of the shaft of femur at the third trochanter level. Cancer Biol Ther 2013;14:193-9.
21. Zhang R, Lao L. A new rat model of bone cancer pain. Methods Mol Biol 2012;851:261-73.
22. Liu Y, Liang Y, Hou B, Liu M, Yang X, Liu C et al. The inhibitor of calcium/calmodulin-dependent protein kinase II KN93 attenuates bone cancer pain via inhibition of KIF17/NR2B trafficking in mice. Pharmacol Biochem Behav 2014;124:19-26.
23. Hang LH, Li SN, Shao DH, Chen Z, Chen YF, Shu WW. Evidence for involvement of spinal RANTES in the antinociceptive effects of triptolide, a diterpene triepoxide, in a rat model of bone cancer pain. Basic Clin Pharmacol Toxicol 2014;115:477-80.
24. Li Y, Cai J, Han Y, Xiao X, Meng XL, Su L et al. Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain. Eur J Pain 2014;18:774-84.
25. Shen W, Hu XM, Liu YN, Han Y, Chen LP, Wang CC et al. CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord. J Neuroinflammation 2014;11:75.
26. de Novellis V, Negri L, Lattanzi R, Rossi F, Palazzo E, Marabese I et al. The prokineticin receptor agonist Bv8 increases GABA release in the periaqueductal grey and modifies RVM cell activities and thermoceptive reflexes in the rat. Eur J Neurosci 2007;26:3068-78.
27. De Felice M, Melchiorri P, Ossipov MH, Vanderah TW, Porreca F, Negri L. Mechanisms of Bv8-induced biphasic hyperalgesia: increased excitatory transmitter release and expression. Neurosci Lett 2012;521:40-5.
28. Watson RP, Lilley E, Panesar M, Bhalay G, Langridge S, Tian SS et al. Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport. Neurogastroenterol Motil 2012;24:65-75.
29. Catalano RD, Lannagan TR, Gorowiec M, Denison FC, Norman JE, Jabbour HN. Prokineticins: novel mediators of inflammatory and contractile pathways at parturition? Mol Hum Reprod 2010;16:311-9.
30. Liu S, Liu YP, Song WB, Song XJ. EphrinB-EphB receptor signaling contributes to bone cancer pain via Toll-like receptor and proinflammatory cytokines in rat spinal cord. Pain 2013;154:2823-35.
31. Zhao J, Zhang H, Liu SB, Han P, Hu S, Li Q et al. Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice. Neuroscience 2013;253:172-82.